PRESENTED BY: DR. ROBERT TRESTMAN & DR. BONNIE HENNIG-TRESTMAN
Many of the symptoms that people with HD experience may alter or impair self-awareness, emotions, impulsivity and irritability, and suspiciousness. Psychiatric medications can help reduce many these symptoms and significantly improve life quality and level of functioning. We will review the different kinds of medications, the symptoms they each target, and the potential benefits and risks of each.
Dr. Robert Trestman
Robert Trestman is Professor and Chair of the Carilion Clinic and Virginia Tech Carilion School of Medicine Department of Psychiatry and Behavioral Medicine. Dr. Trestman has studied the neurobiology and treatment of people with severe mood and personality disorders and conducts translational research on mental health. He has authored over 180 peer-reviewed articles and other publications, and is the co-developer of START NOW, a skills-based psychotherapy in use in five countries. Dr. Trestman has given over 150 regional, national, and international invited presentations and serves on multiple national councils.
Dr. Bonnie Hennig-Trestman
Dr. Bonnie Hennig-Trestman has over 30 years of expertise providing and guiding clinical services to patients and family members suffering from neurodegenerative, physical, and psychiatric illnesses. She received her Bachelor of Arts and her Master of Social Work from Boston University and her Doctorate of Social Work from Capella University. She is an Assistant Professor at Virginia Tech Carilion School of Medicine in the Department of Basic Science Education and the Director of the Carilion Clinic Huntington’s Disease Program in Roanoke, Virginia. She has over two decades of experience working with people who are impacted by Huntington’s Disease. Dr. Hennig-Trestman is a member of the Huntington Study Group (HSG) and the European HD Network (EHDN) and serves on the Board of Directors as the Research Chair for Huntington’s Disease Youth Organization (HDYO).